<DOC>
	<DOCNO>NCT02556216</DOCNO>
	<brief_summary>Bone mineral disease key problem patient kidney disease . The available clinical parameter non-specific , unproven assessment bone metabolism reflect complexity diversity underlie bone pathology . The aim study use bone histology , novel bone marker bone image result establish reliable decision model ( diagnostic tool ) use guide individual therapy .</brief_summary>
	<brief_title>Systematic Study Parameters Chronic Kidney Disease Mineral Bone Disorder ( CKD-MBD )</brief_title>
	<detailed_description>Bone mineral disease key problem patient kidney disease . The available clinical parameter non-specific , unproven assessment bone metabolism reflect complexity diversity underlie bone pathology . In study bone histology parameter include result tetracycline labeling compare non-invasive parameter bone metabolism ( e.g . sclerostin , calciprotein particle ) bone structure obtain imaging ( e.g . bone density ) . The aim study establish reliable decision model ( diagnostic tool ) non-invasive parameter use guide individual therapy . The decision model base single AUC calculation parameter , include determination optimal cutpoint , sensitivity specificity . These result integrate multivariate logistic regression analysis . The result model enable calculate individual probability underlie bone diagnosis single value ( without specific dimension ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Osteodystrophy</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<criteria>Patients kidney disease indication bone biopsy , base clinical , laboratory radiologic finding know malignant bone bone marrow disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>bone biopsy ; bone density</keyword>
</DOC>